Andy Hwang,Vice President Clinical Operations at HOOKIPA, is responsible for leading the Project Teams for the development programs HB-101 (CMV, Phase 2) and HB-201 (HPV). He uses his wealth of knowledge on the life cycle of studies, to align all pre-clinical, manufacturing, regulatory, and clinical operations activities. Andy has over 10 years of experience in clinical trial management, specializing in early Phase 1, first-in-man, global studies. Before joining HOOKIPA, he worked at Novartis Oncology Translational Medicine as a Clinical Trial Head and at Bayer Oncology Business Unit as a Clinical Program Manager. Andy holds a Doctor of Pharmacy degree (PharmD) from the University of Southern California, Los Angeles.